# Maraviroc Abacavir STudy - Effect on Endothelial Recovery

> **NCT01389063** · PHASE4 · UNKNOWN · sponsor: **S.F.L. van Lelyveld** · enrollment: 24 (estimated)

## Conditions studied

- Endothelial Dysfunction

## Interventions

- **DRUG:** Maraviroc

## Key facts

- **NCT ID:** NCT01389063
- **Lead sponsor:** S.F.L. van Lelyveld
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2014-09
- **Final completion:** 2014-10
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2013-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01389063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01389063, "Maraviroc Abacavir STudy - Effect on Endothelial Recovery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01389063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*